Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea

World Journal of Gastroenterology

Volumn 20, Issue 42, 2014, Pages 15837-15844

  Dietrich, Christoph G ^a   Kottmann, Tanja ^b   Alavi, Manuela ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b Private Institute of Medical Statistics   (Germany)

Author keywords

Antibiotics associated diarrhea; Lactobacillus casei; Probiotics

Indexed keywords

ALBUMIN; AMPICILLIN; CLINDAMYCIN; CREATININE; PIPERACILLIN; PROBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; DRUG FORMULATION; ECONOMIC ASPECT; FEMALE; GERMANY; HEALTH CARE COST; HUMAN; INFECTION; INFECTION PREVENTION; INTESTINE MOTILITY; LACTOBACILLUS CASEI; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT CARE; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; REDUCTION; RISK FACTOR; BEVERAGE; CHEMICALLY INDUCED; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DIARRHEA; ECONOMICS; INCIDENCE; MICROBIOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; VERY ELDERLY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BEVERAGES; COST-BENEFIT ANALYSIS; DIARRHEA; FEMALE; GERMANY; HEALTH CARE COSTS; HUMANS; INCIDENCE; LACTOBACILLUS CASEI; MALE; MIDDLE AGED; PILOT PROJECTS; PROBIOTICS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84912142404     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i42.15837     Document Type: Article

References (26)

1. Eser A, Thalhammer F, Burghuber F, Högenauer C, Stockenhuber F, Wenisch C, Widhalm K, Reinisch W. [Probiotics for the prevention of antibiotic-induced diarrhea]. Z Gastroenterol 2012; 50: 1089-1095 [PMID: 23059802 DOI: 10.1055/s-0032-1312950]
2. Bergogne-Bérézin E. Treatment and prevention of antibiotic associated diarrhea. Int J Antimicrob Agents 2000; 16: 521-526 [PMID: 11118872 DOI: 10.1016/S0924-8579(00)00293-4]
3. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101: 812-822 [PMID: 16635227 DOI: 10.1111/j.1572-0241.2006.00465.x]
4. Avadhani A, Miley H. Probiotics for prevention of antibiotic-associated diarrhea and Clostridium difficile-associated disease in hospitalized adults-A meta-analysis. J Am Acad Nurse Pract 2011; 23: 269-274 [PMID: 21649768 DOI: 10.1111/j.1745-7599.2011.00617.x]
5. Saint S, Higgins LA, Nallamothu BK, Chenoweth C. Do physicians examine patients in contact isolation less frequently? A brief report. Am J Infect Control 2003; 31: 354-356 [PMID: 14608302 DOI: 10.1016/S0196-6553(02)48250-8]
6. Vinski J, Bertin M, Sun Z, Gordon SM, Bokar D, Merlino J, Fraser TG. Impact of isolation on hospital consumer assessment of healthcare providers and systems scores: Is isolation isolating? Infect Control Hosp Epidemiol 2012; 33: 513-516 [PMID: 22476279 DOI: 10.1086/665314]
7. Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA 2003; 290: 1899-1905 [PMID: 14532319 DOI: 10.1001/jama.290.14.1899]
8. Koning CJ, Jonkers DM, Stobberingh EE, Mulder L, Rombouts FM, Stockbrügger RW. The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin. Am J Gastroenterol 2008; 103: 178-189 [PMID: 17900321 DOI: 10.1111/j.1572-0241.2007.01547.x]
9. Merenstein DJ, Foster J, D'Amico F. A randomized clinical trial measuring the influence of kefir on antibiotic-associated diarrhea: The measuring the influence of Kefir (MILK) Study. Arch Pediatr Adolesc Med 2009; 163: 750-754 [PMID: 19652108 DOI: 10.1001/archpediatrics.2009.119]
10. Cimperman L, Bayless G, Best K, Diligente A, Mordarski B, Oster M, Smith M, Vatakis F, Wiese D, Steiber A, Katz J. A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults. J Clin Gastroenterol 2011; 45: 785-789 [PMID: 21552138 DOI: 10.1097/MCG.0b013e3182166a42]
11. Sampalis J, Psaradellis E, Rampakakis E. Efficacy of BIO K+ CL1285 in the reduction of antibiotic-associated diarrhea -A placebo controlled double-blind randomized, multi-center study. Arch Med Sci 2010; 6: 56-64 [PMID: 22371721 DOI: 10.5114/aoms.2010.13508]
12. Gao XW, Mubasher M, Fang CY, Reifer C, Miller LE. Doseresponse efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficileassociated diarrhea prophylaxis in adult patients. Am J Gastroenterol 2010; 105: 1636-1641 [PMID: 20145608 DOI: 10.1038/ajg.2010.11]
13. Song HJ, Kim JY, Jung SA, Kim SE, Park HS, Jeong Y, Hong SP, Cheon JH, Kim WH, Kim HJ, Ye BD, Yang SK, Kim SW, Shin SJ, Kim HS, Sung JK, Kim EY. Effect of probiotic Lactobacillus (Lacidofil® cap) for the prevention of antibioticassociated diarrhea: A prospective, randomized, doubleblind, multicenter study. J Korean Med Sci 2010; 25: 1784-1791 [PMID: 21165295 DOI: 10.3346/jkms.2010.25.12.1784]
14. Wenus C, Goll R, Loken EB, Biong AS, Halvorsen DS, Florholmen J. Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink. Eur J Clin Nutr 2008; 62: 299-301 [PMID: 17356555 DOI: 10.1038/sj.ejcn.1602718]
15. Kale-Pradhan PB, Jassal HK, Wilhelm SM. Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: A meta-analysis. Pharmacotherapy 2010; 30: 119-126 [PMID: 20099986 DOI: 10.1592/phco.30.2.119]
16. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B, Shekelle PG. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: A systematic review and meta-analysis. JAMA 2012; 307: 1959-1969 [PMID: 22570464 DOI: 10.1001/jama.2012.3507]
17. Videlock EJ, Cremonini F. Meta-analysis: Probiotics in antibioticassociated diarrhoea. Aliment Pharmacol Ther 2012; 35: 1355-1369 [PMID: 22531096 DOI: 10.1111/j.1365-2036.2012.05104.x]
18. Hungin AP, Mulligan C, Pot B, Whorwell P, Agréus L, Fracasso P, Lionis C, Mendive J, Philippart de Foy JM, Rubin G, Winchester C, de Wit N. Systematic review: Probiotics in the management of lower gastrointestinal symptoms in clinical practice -an evidence-based international guide. Aliment Pharmacol Ther 2013; 38: 864-886 [PMID: 23981066 DOI: 10.1111/apt.12460]
19. Pozzoni P, Riva A, Bellatorre AG, Amigoni M, Redaelli E, Ronchetti A, Stefani M, Tironi R, Molteni EE, Conte D, Casazza G, Colli A. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: A single-center, randomized, double-blind, placebocontrolled trial. Am J Gastroenterol 2012; 107: 922-931 [PMID: 22472744 DOI: 10.1038/ajg.2012.56]
20. McFarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol 2010; 16: 2202-2222 [PMID: 20458757 DOI: 10.3748/wjg.v16. i18.2202]
21. Kotzampassi K, Giamarellos-Bourboulis EJ. Probiotics for infectious diseases: More drugs, less dietary supplementation. Int J Antimicrob Agents 2012; 40: 288-296 [PMID: 22858373 DOI: 10.1016/j.ijantimicag.2012.06.006]
22. Hickson M, D'Souza AL, Muthu N, Rogers TR, Want S, Rajkumar C, Bulpitt CJ. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: Randomised double blind placebo controlled trial. BMJ 2007; 335: 80 [PMID: 17604300 DOI: 10.1136/bmj.39231.599815.55]
23. Doron SI, Hibberd PL, Gorbach SL. Probiotics for prevention of antibiotic-associated diarrhea. J Clin Gastroenterol 2008; 42 Suppl 2: S58-S63 [PMID: 18542041 DOI: 10.1097/MCG.0b013e3181618ab7]
24. Liong MT. Safety of probiotics: Translocation and infection. Nutr Rev 2008; 66: 192-202 [PMID: 18366533 DOI: 10.1111/j.1753-4887.2008.00024.x]
25. Naggie S, Miller BA, Zuzak KB, Pence BW, Mayo AJ, Nichol-son BP, Kutty PK, McDonald LC, Woods CW. A case-control study of community-associated Clostridium difficile infection: No role for proton pump inhibitors. Am J Med 2011; 124: 276. e1-276.e7 [PMID: 21396512 DOI: 10.1016/j.amjmed.2010.10.013]
26. Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: A meta-analysis. Am J Gastroenterol 2012; 107: 1001-1010 [PMID: 22710578 DOI: 10.1038/ajg.2012.179]